Technical Analysis for SNDX - Syndax Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade A 7.55 3.14% 0.23
SNDX closed up 3.14 percent on Friday, May 24, 2019, on 41 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical SNDX trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Bollinger Band Squeeze Range Contraction 3.14%
Narrow Range Bar Range Contraction 3.14%
NR7 Range Contraction 3.14%
NR7-2 Range Contraction 3.14%
20 DMA Resistance Bearish 3.14%
Bollinger Band Squeeze Range Contraction 3.14%
NR7 Range Contraction 3.14%
20 DMA Resistance Bearish 3.14%

Older signals for SNDX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Syndax Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics in oncology. The company's lead product candidate is entinostat, an epigenetic therapy for treatment-resistant cancers, such as breast cancer and lung cancer, as well as other indications comprising solid tumors and hematological malignancies. Its Entinostat is an oral histone deacetylase inhibitor that targets cancer cell growth and resistance pathways that limit the effectiveness and durability of cancer therapies. The company has a collaborative research and development agreement with the National Cancer Institute; and Genentech. Syndax Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Waltham, Massachusetts.
Medicine Chemistry Cancer Clinical Medicine Solid Tumors Breast Cancer Antineoplastic Drugs Cancer Therapies Lung Cancer Pyridines Hematological Malignancies Late Stage Biopharmaceutical Benzamides Carbamates National Cancer Institute
Is SNDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.37
52 Week Low 3.39
Average Volume 197,648
200-Day Moving Average 6.1213
50-Day Moving Average 6.4046
20-Day Moving Average 7.3985
10-Day Moving Average 7.404
Average True Range 0.4451
ADX 21.33
+DI 24.5173
-DI 17.8888
Chandelier Exit (Long, 3 ATRs ) 6.694699999999999
Chandelier Exit (Short, 3 ATRs ) 8.0153
Upper Bollinger Band 7.8893
Lower Bollinger Band 6.9077
Percent B (%b) 0.65
BandWidth 13.267554
MACD Line 0.2374
MACD Signal Line 0.3078
MACD Histogram -0.0704
Fundamentals Value
Market Cap 167.75 Million
Num Shares 22.2 Million
EPS -2.84
Price-to-Earnings (P/E) Ratio -2.66
Price-to-Sales 191.23
Price-to-Book 2.13
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.14
Resistance 3 (R3) 8.12 7.91 8.04
Resistance 2 (R2) 7.91 7.76 7.92 8.00
Resistance 1 (R1) 7.73 7.67 7.82 7.75 7.97
Pivot Point 7.52 7.52 7.57 7.53 7.52
Support 1 (S1) 7.34 7.37 7.43 7.36 7.13
Support 2 (S2) 7.13 7.28 7.14 7.10
Support 3 (S3) 6.95 7.13 7.06
Support 4 (S4) 6.97